aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.
Will the quickly developed vaccines deliver Covid-19 a knockout blow?
Gains in tRNAslation: It’s time for investors to realize the potential of European RNA technologies
Remote electric neuromodulation device approval extended to treatment of chronic migraine
Combining machine learning tools for medical imaging with genetic sequencing nets Sophia Genetics $110M
Alexa, do I have COVID-19?
Venture capitalists find more to Israel than Zionism
Seer Announces Spin Out of PrognomIQ with $55 Million Initial Financing
Adicet Announces Completion of Merger with resTORbio
MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-in-Class Activating RNA-Based Therapeutics
MOBILion Closes $35M Series B Financing Round